James Hoyes
Hoyes’ latest appointment comes shortly after he took on the role of president at EMD Serono, where he was previously chief commercial officer.
He joins Ikaria chairman and CEO Tasse, who is also new to the board.
PhRMA president and CEO John J. Castellani said of their appointments: "Their broad knowledge of the biopharmaceutical research sector will be instrumental in our continual efforts to promote patient-centered policies that support medical innovation. “